{
    "code": "02023959",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02023959",
    "time": "2019-01-18 03:54:50",
    "許可證字號": "衛署藥輸字第023959號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "113\/04\/13",
    "發證日期": "93\/04\/13",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202395901",
    "中文品名": "&quot;隆柏&quot; 立普能膜衣錠5毫克",
    "英文品名": "LEXAPRO TABLETS 5MG",
    "適應症": "鬱症之治療及預防復發，恐慌症，社交焦慮症，泛焦慮症及強迫症之治療。",
    "劑型": "116膜衣錠",
    "包裝": "4-1000粒盒裝",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "主成分略述": [
        "ESCITALOPRAMOXALATE"
    ],
    "限制項目": "02輸　入 54依本署89、12、12衛署藥字第0890035812號公告事項九得免除國內進行臨床試驗之特殊醫療需要之新藥",
    "申請商名稱": "0512001100  禾利行股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F110012000  H. LUNDBECK A\/S",
        "製造廠廠址": "OTTILIAVEJ 9,2500 VALBY, DENMARK",
        "製造廠公司地址": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "9200098910",
            "成分名稱": "ESCITALOPRAM OXALATE",
            "含量描述": "(corresp. to Escitalopram 5 mg)",
            "含量": "6.3900000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "隆柏立普能膜衣錠5mg_10mg_15mg_20mg-中文仿單_2018-01-25-107-02-27.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023959&Seq=017&Type=9"
        },
        {
            "title": "020239590003-blister-104-10-07(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023959&Seq=008&Type=8"
        }
    ]
}